Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium citrate for infant kidney stones
IRCT20250908067187N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of potassium citrate in nephrolithiasis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Reduction or elimination of microlithiasis. Started Oct 2025; status: completed.
02
Drugs
potassium citrate
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20250908067187N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250908067187N1.